Active substance:
- Pseudomonas aeruginosa, serotype 6, strain PA6M-485-JB, Inactivated
- Pseudomonas aeruginosa, serotype 7, strain PA7M-485-347, Inactivated
- Pseudomonas aeruginosa, serotype 6, strain PA6G-485, Inactivated
- Mink enteritis virus, type 2, strain Ithaca, Inactivated
- Pseudomonas aeruginosa, serotype 7/8, strain PA7G-485, Inactivated
- Pseudomonas aeruginosa, serotype 5, strain PA5M-485-P, Inactivated
- Mink enteritis virus, type 1, strain United, Inactivated
- Pseudomonas aeruginosa, serotype 6, strain PA6M-485-JA, Inactivated
- Pseudomonas aeruginosa, serotype 5, strain PA5G-485, Inactivated
- Clostridium botulinum, type C, toxoid
Route of administration:
-
Subcutaneous use
Pharmaceutical form:
-
Suspension for injection
Target species:
-
Mink